TSplus Introduces New Feedback & Roadmap Platform to Enhance the Remote Desktop User Experience 
Think Business, Think Hong Kong strengthens Italy-Hong Kong ties and opens new path for Asian collaboration 
FUTR Announces Q1 2026 Financial Results 
Tenet Reports Third Quarter 2025 Financial Results 
Eguana Announces Third Quarter 2025 Financial Results Anthony Woodward appointed Logicalis Australia CEO
London | 30th June 2021 – Logicalis, an international IT solutions and managed services provider,…
Staff, Patients & Visitors Get Automatic, Secure Access to Wi-Fi 6 and WBA OpenRoaming™ Across Multiple Hospital Campuses
24 Adventist Health hospital campuses will gain access to fast, seamless and secure Wi-Fi without…
Zylpha Launches ‘Pay As You Bundle’ Software Format For Peppermint CX & SharePoint Online Users
New ‘Pay As You Go’ connectors have made legal document bundling faster, more efficient and…
ISARA Corp. Introduces Advance Crypto Agility Suite to Address Critical Cryptographic Blind Spots
Software gives organizations control and insight into their information security infrastructures to minimize vulnerabilities and…
HUTCHMED Announces the Closing of the Global Offering and the Primary Listing in Hong Kong
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., June 30, 2021 (GLOBE NEWSWIRE) —…
Change in Number of Shares and Votes in Immunicum AB (publ)
Press Release 30 June 2021 Change in Number of Shares and Votes in Immunicum AB…
NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670
NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial…
Emergex Receives Regulatory Approval for a Phase I Clinical Trial in Dengue of a T-Cell Priming Vaccine
PRESS RELEASE Emergex Receives Regulatory Approval for a Phase I Clinical Trial in Dengue of…
OSE Immunotherapeutics Announces Manufacturing Agreement with Cenexi for Clinical Batches of CoVepiT, OSE’s Multi-Target Second-Generation COVID-19 Vaccine
NANTES, France and FONTENAY-SOUS-BOIS, France, June 30, 2021 (GLOBE NEWSWIRE) — OSE Immunotherapeutics (ISIN: FR0012127173;…
ObsEva Presents Clinical Data on Open-Label Pilot Study of Yselty® (linzagolix) for the Treatment of Severe Adenomyosis at ESHRE Virtual 37th Annual Meeting
-Two additional abstracts presented on data from ongoing clinical programs: Yselty for the treatment of…
Addex Establishes At-The-Market ADS Equity Sale Program
Geneva, Switzerland, June 30, 2021 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering…
Bone Therapeutics publishes results of ALLOB Phase I/IIa study for the treatment of delayed-union fractures in Stem Cell Research & Therapy
Results showed percutaneous implantation of allogeneic bone-forming cells was well tolerated in patients and led…
PANBELA THERAPEUTICS INCREASES PREVIOUSLY ANNOUNCED BOUGHT DEAL OFFERING OF COMMON STOCK TO $10.0 MILLION
MINNEAPOLIS, June 30, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA) (the “Company” or…
Aerovate Therapeutics Announces Pricing of Upsized Initial Public Offering
BOSTON, June 29, 2021 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage…
MedMira Reports Third Quarter Results FY2021
HALIFAX, Nova Scotia, June 29, 2021 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), reported…
Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass., June 29, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage…
Fennec Announces Results of Annual Meeting
RESEARCH TRIANGLE PARK, N.C., June 29, 2021 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (the “Company”)…
PANBELA THERAPEUTICS ANNOUNCES $5.0 MILLION BOUGHT DEAL OFFERING OF COMMON STOCK
MINNEAPOLIS, June 29, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA) (the “Company” or…
Oyster Point Pharma Provides Key Supply Chain Insight For OC-01 (varenicline) Nasal Spray
PRINCETON, N.J., June 29, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), today…
Cerevel Therapeutics Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., June 29, 2021 (GLOBE NEWSWIRE) — Cerevel Therapeutics (Nasdaq: CERE), a company dedicated…